Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells

被引:66
作者
Blumenthal, RL
Campbell, DE
Hwang, P
DeKruyff, RH
Frankel, LR
Umetsu, DT
机构
[1] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Pediat, Div Allergy & Crit Care Med, Stanford, CA 94305 USA
关键词
alveolar macrophages; tolerance; T cells; immune privilege; CD86; CD28;
D O I
10.1067/mai.2001.112845
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Alveolar macrophages (AMCs) are the most abundant phagocytic cells in the lung, but they present antigen poorly to T cells, Objectives: The objectives of our studies were to more clearly define the mechanisms by which AMCs present antigen to T cells and to determine whether AMCs actively inhibit T-cell activation, Methods: We studied purified human CD4 T cells and compared the capacity of allogeneic AMCs and peripheral blood monocytes to induce T-cell proliferation and cytokine production. Results: We previously demonstrated that human AMCs fail to upregulate expression of B7-1 and B7-2 on stimulation with IFN-gamma, We now demonstrate that AMCs actively induce T-cell unresponsiveness (functional inactivation) in an antigen-specific manner and reduce the capacity of CD4 T cells to respond on secondary stimulation. The induction of unresponsiveness was reversed by the addition of CD28 costimulation or IL-2, However, interruption of Fas/Fas ligand interactions or of B7/CTLA-4 interactions did not prevent unresponsiveness, indicating that neither CTLA-4 triggering nor Fas-induced apoptosis was involved in the induction of T-cell unresponsiveness. Conclusions: These studies indicate that AMCs actively tolerize CD4 T cells in an antigen-specific fashion. We propose that AMCs mediate a form of immune privilege in the lungs that effectively limits immune responses in the pulmonary compartment but has little effect on systemic immunity.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 45 条
  • [1] Agea E, 1998, CLIN EXP ALLERGY, V28, P1359
  • [2] Banchereau J, 1997, TRANSFUS SCI, V18, P313
  • [3] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [4] REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION
    BEVERLY, B
    KANG, SM
    LENARDO, MJ
    SCHWARTZ, RH
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) : 661 - 671
  • [5] BILYK N, 1995, IMMUNOLOGY, V86, P231
  • [6] Bingisser RM, 1998, J IMMUNOL, V160, P5729
  • [7] Blotta MH, 1996, J IMMUNOL, V156, P3133
  • [8] Immune functions and immunopathology of the mucosa of the upper respiratory pathways
    Brandtzaeg, P
    Jahnsen, FL
    Farstad, IN
    [J]. ACTA OTO-LARYNGOLOGICA, 1996, 116 (02) : 149 - 159
  • [9] Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes
    Burastero, SE
    Magnani, Z
    Confetti, C
    Abbruzzese, L
    Oddera, S
    Balbo, P
    Rossi, GA
    Crimi, E
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) : 1136 - 1142
  • [10] Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
    Cella, M
    Scheidegger, D
    PalmerLehmann, K
    Lane, P
    Lanzavecchia, A
    Alber, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 747 - 752